Pulmova 801 mg (Tablet)

Unit Price: ৳ 125.00 (1 x 10: ৳ 1,250.00)

Strip Price: ৳ 1,250.00

Medicine Details

Treatment of mild to moderate Idiopathic Pulmonary Fibrosis (IPF)
Novel agent with anti-inflammatory, antioxidant, and anti-fibrotic properties
Improves lung function and reduces acute exacerbations in patients with IPF
Suppresses TGF-β1, a key cytokine involved in fibrogenesis
Downregulates expression of pro-inflammatory cytokines
Inhibits influx of inflammatory cells and increased pulmonary vascular permeability
Orally administered with food
Dosage titration recommendations for adults with IPF
Dosage adjustments for gastrointestinal events, photosensitivity reaction, and hepatic function
Drug interactions with moderate and strong CYP1A2 inhibitors
Reduced incidence of adverse reactions observed in fed group
Contraindications: hypersensitivity, concomitant use of fluvoxamine, severe hepatic impairment, severe renal impairment
Common side effects: nausea, rash, abdominal pain, upper respiratory tract infection, diarrhea, fatigue
Rare side effects: photosensitivity reaction, decreased appetite, pruritus, asthenia, dysgeusia, non-cardiac chest pain
Precautions for elevated liver enzymes, photosensitivity, rash, and gastrointestinal disorders
Use in special populations: children & adolescents, hepatic impairment, renal impairment, smokers
Limited clinical experience with overdose
Storage conditions: cool, dry place; protect from light & moisture; keep out of reach of children

Treatment of mild to moderate Idiopathic Pulmonary Fibrosis (IPF)
Anti-inflammatory
Antioxidant
Anti-fibrotic
Improvement of lung function
Reduction of acute exacerbations in patients with IPF
Inhibition of inflammatory cells influx
Dosage titration recommendations
Dosage adjustments for gastrointestinal events, photosensitivity reaction, and hepatic function
Drug interaction management
Contraindications management
Side effects management
Precautions and warnings
Use in special populations
Limited clinical experience with overdose